1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Chison Medical Technologies Co., Ltd.

Chison Medical Technologies Co., Ltd.

688358.SS
Chison Medical Technologies Co., Ltd.CN flagShanghai Stock Exchange
33.24
CNY
-2.21
- -
3.73BMarket Cap
Chison Medical Technologies Co., Ltd.
688358.SS
(Shanghai Stock Exchange)

Recent

price

33.24

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2
3.24
3.88
4.27
2.98
3.54
3.38
4.39
4.2
3.89
4.07
Revenue per Share
0.36
0.76
1.13
1.21
0.89
1
0.94
1.33
1.26
1.04
1.15
Basic EPS, GAAP
0.41
0.57
0.78
0.83
0.46
0.01
0.1
0.47
1.18
0.83
-0.13
Free Cash Flow per Basic Share
0.36
0.16
0.22
0.94
0.72
0.57
0.36
0.71
0.8
1
0.51
Dividend per Share
0.65
1.33
1.93
2.5
2.03
2.38
3.14
3.8
4.21
3.93
3.8
Book Value per Share
0.89
1.42
2.19
13.24
10.48
10.87
11.47
12.24
12.56
12.16
12.07
Tangible Book Value per Share
84
84
84
87
112
112
113
110
112
112
112
Basic Weighted Avg Shares
167
272
327
370
333
398
381
484
469
436
457
Sales/Revenue/Turnover
14.86
28.64
32.46
30.65
27.18
21.78
20.44
27.08
23.89
22.99
23.59
Operating Margin (%)
5
5
6
7
8
10
13
14
15
14
- -
Depreciation Expense
30
64
95
105
100
112
106
146
141
116
129
Net Income, GAAP
9.1
13.47
11.22
10.86
10.65
9.69
8.07
9.69
10.42
9.44
10.81
Effective Tax Rate (%)
18.25
23.58
29.07
28.43
29.91
28.27
27.79
30.27
29.98
26.73
28.18
Profit Margin (%)
52
112
184
1,145
1,141
1,131
1,150
1,203
1,238
1,211
1,194
Working Capital
- -
- -
- -
- -
1
1
6
6
3
2
3
LT Debt
76
144
209
1,171
1,193
1,246
1,314
1,369
1,421
1,383
1,378
Total Equity
- -
58.02
50.68
14.56
6.85
6.42
5.58
8.78
7.17
6.46
7.01
Return on Invested Capital (%)
- -
83.26
69.22
55.2
44.27
44.28
32.95
32.97
31.16
25.42
30.36
Return on Capital (%)
- -
77.56
69.44
55.44
44.94
45.44
34.03
37.95
31.67
25.63
30.79
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
4
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
112
112
112
Market Capitalization
2,712
3,478
3,335

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
1,405
1,426
1,465
Cash, Cash Equivalents & STI
1,101
1,122
1,148
Accounts Receivable, Net
162
183
184
Inventories
126
107
115
Total Current Liabilities
167
149
270
Payables & Accruals
- -
- -
- -
ST Debt
4
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
3.05%
-2.61%
Free Cash Flow
- -
352.56%
-29.64%
Net Income, GAAP
- -
4.84%
-17.09%
Sales/Revenue/Turnover
- -
6.41%
-7.02%
Total Cash Common Dividend
- -
15.55%
25%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
141
107
115
106
469
2025
128
108
93
- -
436
2026
127
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.41
- -
- -
- -
1.26
2025
0.37
- -
- -
- -
1.04
2026
0.41
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.8
2025
- -
- -
- -
- -
1
2026
0.3
- -
- -
- -
- -
Similar Companies
Clarity Pharmaceuticals Ltd (CU6.AX)
Doctorglasses Chain Co.,Ltd. (300622.SZ)
Spectral AI, Inc. (MDAI)
Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
Japan Eyewear Holdings Co., Ltd. (5889.T)
Sugentech Inc. (253840.KQ)
Business
Chison Medical Technologies Co., Ltd. Chison Medical Technologies Co., Ltd. (688358.SS) manufactures and sells diagnostic ultrasound systems principally for medical imaging applications in China and internationally. The company offers a broad portfolio of ultrasound equipment, including cart-based systems, portable ultrasound devices, handheld ultrasound probes, black-and-white (B&W) ultrasound models, and high-performance color Doppler systems; its SonoFamily product line encompasses SonoMax, SonoAir, and SonoEye series for point-of-care, general imaging, women's health, cardiovascular, radiology, vascular, musculoskeletal (MSK), obstetrics, anesthesiology, emergency, and veterinary uses; supporting equipment includes mobile, vehicle-mounted imaging devices, related instrumentation, electronic components, and accessories. Founded in 1996 and headquartered in Wuxi, Jiangsu Province, China, Chison Medical Technologies maintains research and development centers in China and the United States, with sales networks spanning more than 100 countries and certifications including FDA, CE, and KFDA. The company operates primarily in the medical devices sector, targeting hospitals, clinics, scientific research institutions, and strategic partners across domestic and overseas markets in departments such as ultrasound, obstetrics and gynecology, cardiology, oncology, and pain management. Recent developments include the grand opening of the CHISON Global Ultrasound Training Center and the launch of SonoPort, the newest member of the SonoFamily series, in 2024; a strategic cooperation agreement with EverBridge Medical in April 2024 to advance global ultrasound solutions and "clinical + ultrasound" innovations; and the 2023 introduction of the expanded SonoFamily lineup transforming portable ultrasound offerings.